Literature DB >> 8417124

Generation of diacylglycerol and ceramide during homologous complement activation.

F Niculescu1, H Rus, S Shin, T Lang, M L Shin.   

Abstract

Formation of sublytic terminal complement complexes (TCC) on nucleated cells produces transient increase in [Ca2+]i and activates protein kinase C. The present study is to evaluate whether TCC can generate endogenous signal messengers other than Ca2+ that regulate cell activities by measuring mass-levels of sn-1,2-diacylglycerol (DAG) and ceramide. As targets, lymphoblastoid human B cell lines JY25 and its mutant JY5 were used. JY5, cells deficient in glycosylphosphatidylinositol-anchored proteins with higher lytic susceptibility to human complement, are four times more efficient in forming C5b-9. When cells sensitized with limited anti-class II IgG were exposed to human serum to generate sublytic TCC, a sustained increase in DAG and ceramide was observed with a maximum 3.6-fold DAG increase over basal level in JY25 and 2.8-fold in JY5, and 6.3-fold ceramide increase in JY25 and 2.8-fold in JY5. The effect of TCC was evaluated with C7-deficient human serum (C7D) +/- C7 and also with C5b6, C7, C8, and C9 proteins. The DAG and ceramide increase by C7D + C7 over C7D control were 1.6- and 1.8-fold, respectively, in JY25, and 2.3-, and two-fold in JY5. TCC activation also induced an increased hydrolysis of sphyingomyelin and phosphatidylcholine. In addition, DAG increase by TCC was primarily achieved by C5b-7 and preincubation of cells with pertussis toxininhibited DAG increase, suggesting an involvement of a pertussis toxin-sensitive GTP-binding protein. As important signal transduction molecules, DAG and ceramide generated in response to TCC assembly, could participate in cell activation during inflammation and repair.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.

Authors:  L Liu; W Li; Z Li; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  T cell activation by terminal complex of complement and immune complexes.

Authors:  Anil K Chauhan; Terry L Moore
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells.

Authors:  Manu Banadakoppa; Meena Balakrishnan; Chandra Yallampalli
Journal:  Am J Reprod Immunol       Date:  2018-08-12       Impact factor: 3.886

Review 4.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 5.  Membrane signaling by complement C5b-9, the membrane attack complex.

Authors:  A Nicholson-Weller; J A Halperin
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 6.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

Review 7.  Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Jacob Danoff; Hassan Madani; Adam Sugarman; Florin Niculescu; Petru A Mircea; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

8.  Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase.

Authors:  Florian Langer; Brigitte Spath; Cornelia Fischer; Moritz Stolz; Francis A Ayuk; Nicolaus Kröger; Carsten Bokemeyer; Wolfram Ruf
Journal:  Blood       Date:  2013-01-11       Impact factor: 22.113

Review 9.  Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets.

Authors:  Catherine B Xie; Dan Jane-Wit; Jordan S Pober
Journal:  Am J Pathol       Date:  2020-03-16       Impact factor: 4.307

Review 10.  Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.

Authors:  F Niculescu; H Rus
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.